Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 3 of 15

→ [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad)
Slide 3
Back to 2
Continue to 4
 
Back to 2
Continue to 4
 

Novo Nordisk A/S (NYSE:NVO)

Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
6 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$133.60 (0.4% Upside)

About Novo Nordisk A/S

Novo Nordisk A/S logoNovo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/18/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00
4/12/2024BMO Capital MarketsInitiated CoverageOutperform$163.00
4/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00
3/20/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00
2/20/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$140.00
2/14/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$140.00
2/1/2024Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$120.00 ➝ $140.00
1/23/2024Morgan StanleyInitiated CoverageOverweight$120.00
1/16/2024UBS GroupInitiated CoverageNeutral
1/12/2024Cantor FitzgeraldReiterated RatingOverweight
Slide 3
Back to 2
Continue to 4
 

[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)

Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls.

Claim your free seat by clicking here now.

More From MarketBeat
348 million Americans lives to END as we know it?
from The Oxford Club
20 High-Yield Dividend Stocks that Could Ruin Your Retirement
from MarketBeat
Crypto Pioneer Says: “The last crypto bull market has begun.”
from InvestorPlace
15 Healthcare Stocks that Analysts Love in a Post-Pandemic World
from MarketBeat
Invest in the "Trojan Horse" of Alzheimer's Treatment
from Behind the Markets
15 Stocks That Insiders Won't Stop Buying
from MarketBeat